Patent foramen ovale and atrial septal defect.
atrial septal defect
congenital heart disease
echocardiography
patent foramen ovale
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
22
10
2019
accepted:
07
02
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
24
6
2021
Statut:
ppublish
Résumé
Atrial septal defects (ASD) are among the most common congenital heart diseases encountered in adulthood. Patent foramen ovale (PFO) is present in up to 25% of the population. ASD could present as isolated lesion or in association with more complex congenital heart disease form as tetralogy of Fallot, or Ebstein's anomaly of tricuspid valve. There is a wide range of clinical presentation ranging from asymptomatic subjects surviving to adulthood undiagnosed to subjects presenting with right heart failure and severe pulmonary vascular disease (Eisenmenger syndrome). This manuscript is an in depth review of the complex atrial septation, the variable clinical presentation of ASD and PFO, and its clinical and therapeutic implications.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2172-2184Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Kirklin JW. Cardiac Surgery. New York, NY: John Wiley & Sons; 1986.
Hobbs CA, Cleves MA, Keith C, Ghaffar S, James SJ. NKX2.5 and congenital heart defects: a population-based study. Am J Med Genet A. 2005;134A(2):223-225.
Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424(6947):443-447.
Holt M, Oram S. Familial heart disease with skeletal malformations. Br Heart J. 1960;22:236-242.
Katsouras CS, Thomadakis C, Michalis LK. Cardiac Ellis-van Creveld syndrome. Int J Cardiol. 2003;87(2-3):315-316.
Van Mierop LHS. Embryology of the Atrioventricular Canal Region and Pathogenesis of Endocardial Cushion Defects. Philadelphia: WB Saunders; 1976.
Giannopoulos A, Gavras C, Sarioglou S, Agathagelou F, Kassapoglou I, Athanassiadou F. Atrial septal aneurysms in childhood: prevalence, classification, and concurrent abnormalities. Cardiol Young. 2014;24:453-458.
Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991-999.
Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368:1083-1091.
Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092-1100.
Khan AR, Bin Abdulhak AA, Sheikh MA, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. J Am Coll Cardiol Intv. 2013;6:1316-1323.
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011-1021.
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033-1042.
Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet. 2000;356:1648-1651.
Schwedt TJ, Dodick DW. Patent foramen ovale and migraine - bringing closure to the subject. Headache J Head Face Pain. 2006;46:663-671.
Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double- blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-1404.
Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized con- trolled trial. Eur Heart J. 2016;23:ehw027.
Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648-1651.
Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493-495.
Bove AA. Risk of decompression sickness with patent foramen ovale. Undersea Hyperb Med. 1998;25:175.
Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J. 2004;25:1014-1020.
Billinger M, Zbinden R, Mordasini R, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011;97(23):1932-1937.
Honěk J, Srámek M, Sefc L, et al. Effect of catheter-based patent foramen ovale closure on the occurrence of arterial bubbles in scuba divers. JACC Cardiovasc Interv. 2014;7(4):403-408.
Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47:64-66.
Mojadidi MK, Gevorgyan R, Noureddin N, et al. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome. Catheter Cardiovasc Interv. 2015;86(4):701-707.
Hildick-Smith D, Behan M, Haworth P, Rana B, Thomas M. Patent foramen ovale closure without echocardiographic control: use of "standby" intracardiac ultrasound. JACC Cardiovasc Interv. 2008;1(4):387-391.
Rana BS, Thomas MR, Calvert PA, Monaghan MJ, Hildick-Smith D. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc Imaging. 2010;3(7):749-760.
Ho ML, Bhalla S, Bierhals A, Gutierrez F. MDCT of partial anomalous pulmonary venous return (PAPVR) in adults. J Thorac Imaging. 2009;24(2):89-95.
Rabinovitch M. Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant. 1999;11:1041-1053.
Pollick C, Sullivan H, Cujec B, Wilansky S. Doppler color-flow imaging assessment of shunt size in atrial septal defect. Circulation. 1988;78(3):522-528.
Valdes-Cruz LM, Horowitz S, Mesel E, Sahn DJ, Fisher DC, Larson D. A pulsed Doppler echocardiographic method for calculating pulmonary and systemic blood flow in atrial level shunts: validation studies in animals and initial human experience. Circulation. 1984;69(1):80-86.
Lighty GW Jr, Gargiulo A, Kronzon I, Politzer F. Comparison of multiple views for the evaluation of pulmonary arterial blood flow by Doppler echocardiography. Circulation. 1986;74(5):1002-1006.
Sanders SP, Yeager S, Williams RG. Measurement of systemic and pulmonary blood flow and QP/QS ratio using Doppler and two-dimensional echocardiography. Am J Cardiol. 1983;51(6):952-956.
Mehta RH, Helmcke F, Nanda NC, Hsiung M, Pacifico AD, Hsu TL. Transesophageal Doppler color flow mapping assessment of atrial septal defect. J Am Coll Cardiol. 1990;16(4):1010-1016.
Souteyrand G, Motreff P, Lusson JR, et al. Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr. 2006;7(2):147-154.
Baim DS, ed. Grossman's Cardiac Catheterization, Angiography and Intervention, 7th edn. Philadelphia: Lippincott Williams & Wilkins; 2006.
Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57(11):e101-e198.
Ali S, George LK, Das P, Koshy SK. Intracardiac echocardiography: clinical utility and application. Echocardiography. 2011;28(5):582-590.
Mullen MJ, Dias BF, Walker F, Siu SC, Benson LN, McLaughlin PR. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol. 2003;41(2):285-292.
Packer DL, Stevens CL, Curley MG, et al. Intracardiac phased-array imaging: methods and initial clinical experience with high resolution, under blood visualization: initial experience with intracardiac phased-array ultrasound. J Am Coll Cardiol. 2002;39(3):509-516.
Kim NK, Park SJ, Shin JI, Choi JY. Eight-French intracardiac echocardiography - safe and effective guidance for transcatheter closure in atrial septal defects. Circ J. 2012;76(9):2119-2123.
Rigatelli G, Cardaioli P, Giordan M, et al. Transcatheter intracardiac echocardiography-assisted closure of interatrial shunts: complications and midterm follow-up. Echocardiography. 2009;26(2):196-202.